Edwards Lifesciences Corporation (EW) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings and welcome to Edwards Life Sciences' fourth quarter 2025 results conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note that this conference is being recorded. I will now turn the conference over to your hosts, Gerri-Ann Sarte. Thank you. You may begin. Thank you. Good afternoon and thank you for joining us. This is Gerri-Ann Sarte. I am the incoming Senior Vice President of Investor Relations. With me on today's call is our CEO, Bernard Zavigian, and our CFO, Scott Ullum. Also joining us for the Q&A portion of the call will be Dan Lippis, our Global Leader of TAVR, and Devine Chopra, who has global responsibility for TMTT, Surgical, and IHFM. Just after the close of regular trading, Edwards Life Sciences released fourth quarter and full year 2025 financial results. During today's call, management will discuss the results included in the press release and accompanying financial results. Greetings and welcome to Edwards Life Sciences fourth quarter 2025 results conference call. Greetings and welcome to Edwards Life Sciences' fourth quarter 2025 results conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note that this conference is being recorded. I will now turn the conference over to your hosts. Gerianne Sarte. Thank you. You may begin. Thank you. Good afternoon and thank you for joining us. This is Gerianne Sarte. I am the incoming ...